TERI KEECHLE

Specialty focus area includes Enodcinology

• Spearhead territory development and strategic account management for rare endocrine disorders, specializing in Cushing’s syndrome and Acromegaly, across academic centers and community endocrinology practices

Specialty focus area includes Genetics, Hematology/Oncology, Gastroenterology, Pulmonology, and in office/ambulatory Infusion Centers

• Led as Regional Certified Field Trainer, play a crucial role in the development and success of field teams and new hires.

• Led Komodo and IQVIA implementation to improve regional performance, track progress, and achieve strategic objectives.

• Executed targeted educational programs and resources to increase awareness and understanding of Gaucher Disease/Therapy which led to patient testing and new patient starts/switches.

• Led region as Compass Champion to bridge gap between technology and operational needs, driving enhanced efficiency and performance across region through effective platform utilization.

• Improved patient outcomes by identifying and in-servicing infusion centers throughout territory.

• 2022 YTD rank 4/12, 2 Naïve/Switch patients along with 2 other patient switches that were ineligible for Substrate Reduction therapy.

• Achieved 81.25% net commercial patient growth and grew overall territory by 25%.

• Awarded Marketing Preceptorship which entailed patient FIND Optimization by analyzing data claims and machine learning leads.

• Collaborated cross-functionally with Marketing, Training, Compliance, and Senior Leadership to analyze and explore new vendor partnerships, data leads, and other resources resulting in a new vendor partnership and improved AI accuracy through current model re-optimization.

• Collaborated with Training and Marketing to develop a comprehensive training and implementation plan of new offerings and AI reoptimization.

• Cross-collaborated with the Thought Leader Liaison to conduct Gaucher’s

first Peer Journal Review with the largest targeted account, Texas Oncology.

• Launched Xempozyme-first Enzyme Replacement Therapy for ASMD.

• Developed Key Opinion Leader/National Speaker for Gaucher Disease.

• Led iFind Strikeforce team, a dedicated national team of experts who are responsible for strategy development, prioritization, and deployment of leads.

• Led region as Definitive Healthcare Regional Champion, analysis of regional claims data leads and worked closely with vendor to enhance offerings.

• Led region as primary advocate and expert for Veeva CRM and worked closely with IT and operations to optimize platform according to specific needs of field.

Specialty focus area includes Genetics, Cardiology, Nephrology, Neurology, and in office/ambulatory Infusion Centers

• Achieved Circle of Excellence Award, YTD rank 1/23.

• Developed Key Opinion Leader/National Speaker for Fabry Disease.

• Executed targeted educational programs and resources to increase awareness and understanding of Fabry Disease/Therapy which led to patient testing and new patient starts/switches.

• Improved patient outcomes by identifying and in-servicing infusion centers throughout territory.

• Led region as primary advocate and expert for Veeva CRM and worked closely with IT and operations to optimize platform according to specific needs of field.